Voglibose
Strengths: 0.2 mg, 0.3 mg
Dosage Form: Tablets
Description:
Voglibose is an alpha-glucosidase inhibitor that delays the absorption of glucose in the intestine, helping to reduce postprandial blood sugar spikes in type 2 diabetes.
Key Features:
o Targets post-meal glucose rise
o Suitable as monotherapy or add-on
o Low risk of hypoglycemia
Precautions:
Use with caution in patients with gastrointestinal disorders. Should be taken with the first bite of a meal.